Intrexon granted the Sanford-Burnham Medical Research Institute access to its Laser-Enabled Analysis and Processing instrument and RheoSwitch Therapeutic System. The technologies will help the research institute build its collection of human induced pluripotent stem cells. In return, Intrexon may get commercial and patent rights to technology developments arising from the collaboration.
Intrexon helps Sanford-Burnham create iPSC collection
SmartBrief Job Listings for Health Care
|Chief Financial Officer||
B. E. Smith
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|